Knowledge, attitudes, and acceptability of direct-acting antiviral hepatitis C treatment among people incarcerated in jail: A qualitative study.
Knowledge, attitudes, and acceptability of direct-acting antiviral hepatitis C treatment among people incarcerated in jail: A qualitative study.
复制标题
在监狱中被监禁的人中直接作用抗病毒C治疗的知识，态度和可接受性：一项定性研究。
DOI：
10.1371/journal.pone.0242623
复制
发表时间：
2020
期刊：
影响因子：
3.7
通讯作者：
MacDonald R
中科院分区：
文献类型：
--
作者：
Akiyama MJ;Ross J;Rimawi F;Fox A;Jordan AO;Wiersema J;Litwin AH;Kaba F;MacDonald R
虽然美国监狱是从事丙型肝炎护理的关键地点，但短期逗留往往不允许在监狱中接受治疗。因此，与监禁后的丙型肝炎病毒护理相联系是至关重要的。然而，人们对美国监狱中涉及司法的个人对丙型肝炎治疗的可接受性知之甚少。这项研究的目的是了解纽约市监狱系统中丙型肝炎病毒携带者对丙型肝炎治疗的知识、态度和可接受性。我们利用临床数据报告在纽约监狱招募了36名丙型肝炎病毒抗体阳性的人，并进行了半结构化访谈，以探讨参与者在监狱中和回到社区后对丙型肝炎病毒治疗的态度。我们继续采访，直到达到主题饱和，并使用归纳式、主题化的方法分析采访。参与者大多是男性，拉丁裔/O，平均年龄40岁。几乎所有人都知道自己是丙型肝炎抗体阳性。三分之二的参与者对新的丙型肝炎治疗方法有一定的了解。主要主题包括：1)对影响对丙型肝炎病毒治疗态度的新丙型肝炎病毒治疗方法的可变知识，2)其他被监禁个人在交流丙型肝炎病毒相关知识方面的重要性，3)监禁期间的脆弱性和对治疗中断的恐惧，4)对复发到积极药物使用和丙型肝炎病毒再感染的担忧，5)相互竞争的优先事项(例如其他医疗合并症、持续药物使用和住房)，6)社会支持和家庭的重要性。在监狱环境中，以患者为中心增加治疗接受率的方法应侧重于促进与丙型肝炎病毒相关的知识，包括利用同行进行知识传播。此外，过渡性护理计划应确保监狱中的丙型肝炎病毒携带者有量身定做的出院计划，重点放在相互竞争的优先事项上，如住房不稳定、社会支持和药物使用障碍的治疗。
While U.S. jails are critical sites for engagement in HCV care, short lengths-of-stay often do not permit treatment in jail. Therefore, linkage to HCV care after incarceration is crucial. However, little is known about HCV treatment acceptability among justice-involved individuals in U.S. jails. The goal of this study was to understand knowledge, attitudes, and acceptability of HCV treatment among people living with HCV in the New York City (NYC) jail system. We recruited 36 HCV-antibody-positive individuals in the NYC jails using clinical data reports and performed semi-structured interviews to explore participants’ attitudes toward HCV treatment in jail and following return to the community. We continued interviews until reaching thematic saturation and analyzed interviews using an inductive, thematic approach. Participants were mostly male, Latina/o, with a mean age of 40 years. Nearly all were aware they were HCV antibody-positive. Two thirds of participants had some awareness of the availability of new HCV therapies. Key themes included: 1) variable knowledge of new HCV therapies affecting attitudes toward HCV treatment, 2) the importance of other incarcerated individuals in communicating HCV-related knowledge, 3) vulnerability during incarceration and fear of treatment interruption, 4) concern for relapse to active drug use and HCV reinfection, 5) competing priorities (such as other medical comorbidities, ongoing substance use, and housing), 6) social support and the importance of family. Patient-centered approaches to increase treatment uptake in jail settings should focus on promoting HCV-related knowledge including leveraging peers for knowledge dissemination. In addition, transitional care programs should ensure people living with HCV in jail have tailored discharge plans focused on competing priorities such as housing instability, social support, and treatment of substance use disorders.
登录
查看更多内容
影响因子：
2.5
作者：
Lafferty, Lise;Rance, Jake;Treloar, Carla
通讯作者：
Treloar, Carla
影响因子：
7.7
作者：
Kariminia, A.;Butler, T. G.;Law, M. G.
通讯作者：
Law, M. G.
影响因子：
2.5
作者：
Aspinall, E. J.;Mitchell, W.;Hutchinson, S. J.
通讯作者：
Hutchinson, S. J.
影响因子：
3.7
作者：
Akiyama, Matthew J.;Columbus, Devin;Carmody, Ellie
通讯作者：
Carmody, Ellie
DOI：
10.1097/qai.0b013e31821e9f41
发表时间：
2011-08-15
期刊：
Journal of acquired immune deficiency syndromes (1999)
影响因子：
--
作者：
Adams J;Nowels C;Corsi K;Long J;Steiner JF;Binswanger IA
通讯作者：
Binswanger IA